Has Cencora (COR) been one of those stocks this year? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.

The fact that multiple Cencora, Inc. (NYSE:COR) insiders offloaded a considerable amount of shares over the past year could have raised some eyebrows amongst investors. When analyzing insider ...

Shares of Cencora Inc. COR slid 1.38% to $274.56 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 0.23% to 5,062.25 and Dow ...

Alto and Cencora are collaborating to deliver enhanced patient support services and streamline access to prescribed specialty medications. The collaboration leverages Cencora’s patient support ...

Cencora, Inc. (NYSE:COR – Free Report) – Stock analysts at Leerink Partnrs raised their FY2028 EPS estimates for shares of Cencora in a note issued to investors on Wednesday, April 2nd.

Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Second Quarter of Fiscal 2025 on Wednesday, May 7, 2025, prior to the opening of trading on the New York ...

Cencora Stock Up 1.2 % Shares of COR stock opened at $264.02 on Wednesday. Cencora, Inc. has a 12 month low of $214.77 and a 12 month high of $265.44. The stock has a market cap of $51.20 billion ...

Wells Fargo raised the firm’s price target on Cencora (COR) to $274 from $251 and keeps an Equal Weight rating on the shares. The firm is updating its model following Cencora’s results and ...

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)-- Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Second Quarter of Fiscal 2025 on Wednesday, May 7, 2025, prior to the ...